5 tracked fund houses held SHILPAMED in Aug 2026. None entered or exited.
All tracked schemes together held 71.38 lakh shares, 3.65% of equity, worth ₹678 cr at the end of Aug 2026.
Index and arbitrage funds held 0.16% of equity; they are left out of the fund-house counts.
Top buyer Samco Mutual Fund, +0.01% of equity. Top seller Aditya Birla Sun Life Mutual Fund, −0.18% of equity. Index and arbitrage funds hidden.
FPI category I + II, % of total shares · 3 named at 1% or more
FPIs named at 1% or more on 30 Jun 2026: COHESION MK BEST IDEAS SUB-TRUST 2.17%; DOVETAIL INDIA FUND CLASS 5 SHARES 1.71%; ELM PARK FUND LIMITED 1.18%.
of promoter holding · 3.50% of total shares
Promoters had pledged 68.50 lakh of their 7.85 cr shares on 30 Jun 2026; 68.50 lakh encumbered in all (pledge, NDU and other).
percentile 100 of 30 days collected
111 shares, under 0.01% of equity in SLBS open positions at the end of 25 Sep 2026; that day sits at percentile 100 of 30 days collected. No SLBM trades in SHILPAMED on 25 Sep 2026.
percentile 14 of 29 days collected · ₹129 cr financed
20.42 lakh shares, 1.04% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 14 of 29 days collected.
20-day average 39.5% · percentile 13 of 30 days collected
32.4% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 39.5%; that day sits at percentile 13 of 30 days collected.
SHILPAMED has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. On 25 Sep 2026 NSE listed SHILPAMED under long-term ASM stage 1. Pledge invocations are not collected yet.